MedPath

A study related with the patients who are suffering from pittaja mootrakrichra disease and the diaease managed by giving orally trunapanchmoola kwatha.

Phase 1
Conditions
Health Condition 1: N390- Urinary tract infection, site notspecified
Registration Number
CTRI/2020/06/026107
Lead Sponsor
Dr Samira Dattatray Sapre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients suffering from Pittaja Mootrakrichra like peeta mootrata, kruchra mootrata ,sa daha mootrata , sa rakta mootrata and muhur muhur mootrata

Exclusion Criteria

Active genital herpes

Uterine , cervical ,vaginal ,urethral cancer

Tubercular cystitis , vaginitis

Benign and malignant bladder tumors

Patients having other systemic disorders like diabetes ,sexually trasmitted diseases ,HIV, HBsAG ,Pregnant womens

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effects of trunapanchmoola kwatha in the management of piittaja mootrakrichraTimepoint: folloe up on 7th day and 15 th day .The cure shall be assessed in two follow ups
Secondary Outcome Measures
NameTimeMethod
To study pittaja mootrakrichrta in details. <br/ ><br>To reduce urinary complaints. <br/ ><br>To study the properties of trunapanchmoola kwatha.Timepoint: 15 days
© Copyright 2025. All Rights Reserved by MedPath